These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17386830)

  • 1. Neurohormonal activation in populations susceptible to heart failure.
    Arnlöv J; Vasan RS
    Heart Fail Clin; 2005 Apr; 1(1):11-23. PubMed ID: 17386830
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurohormonal upregulation in heart failure.
    Tang WH; Francis GS
    Heart Fail Clin; 2005 Apr; 1(1):1-9. PubMed ID: 17386829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure.
    Gademan MG; Swenne CA; Verwey HF; van der Laarse A; Maan AC; van de Vooren H; van Pelt J; van Exel HJ; Lucas CM; Cleuren GV; Somer S; Schalij MJ; van der Wall EE
    J Card Fail; 2007 May; 13(4):294-303. PubMed ID: 17517350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?].
    Pérez-Villa F; Roig E; Ferrer E; Cuppoletti A; Llancaqueo M; Jiménez W; Sanz G
    Rev Esp Cardiol; 2004 Aug; 57(8):725-31. PubMed ID: 15282060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine activation in acute myocardial infarction.
    Levine TB
    Am J Cardiol; 1990 May; 65(19):32I-34I. PubMed ID: 1970921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aging hypertensive heart: a brief update.
    Susic D; Frohlich ED
    Nat Clin Pract Cardiovasc Med; 2008 Feb; 5(2):104-10. PubMed ID: 18223542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular pharmacology in the 90s: where are we?].
    Marín Huerta E; Rayo I
    Rev Esp Cardiol; 1994 Jun; 47(6):390-402. PubMed ID: 8066311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Left-ventricular hypertrophy and left heart insufficiency: towards cause-oriented therapy].
    Lüscher TF
    Praxis (Bern 1994); 1996 Feb; 85(8):215-7. PubMed ID: 8701187
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting heart failure therapeutics: a historical perspective.
    Murphy GA; Fiuzat M; Bristow MR
    Heart Fail Clin; 2010 Jan; 6(1):11-23. PubMed ID: 19945056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurohumoral activation and remodeling after acute myocardial infarct and the effect of angiotensin-converting enzyme inhibitors].
    Dúbrava J; Cagán S
    Bratisl Lek Listy; 1993 Feb; 94(2):88-93. PubMed ID: 8102588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
    Weber KT
    J Am Coll Cardiol; 2004 Sep; 44(6):1308-10. PubMed ID: 15364337
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From cardiovascular risk to chronic heart failure].
    Ertl G
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():17. PubMed ID: 14694837
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF; Núñez TJ; Odreman R; de Dávila CA
    Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.